JH-X-119-01
CAS No. 2227368-54-7
JH-X-119-01 ( —— )
产品货号. M24010 CAS No. 2227368-54-7
JH-X-119-01 是一种高效、选择性的 IRAK-1 共价抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1397 | 有现货 |
|
| 10MG | ¥2109 | 有现货 |
|
| 25MG | ¥3692 | 有现货 |
|
| 50MG | ¥5282 | 有现货 |
|
| 100MG | ¥7038 | 有现货 |
|
| 200MG | ¥9450 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1406 | 有现货 |
|
生物学信息
-
产品名称JH-X-119-01
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述JH-X-119-01 是一种高效、选择性的 IRAK-1 共价抑制剂。
-
产品描述JH-X-119-01 is a highly potent and selective covalent inhibitor of IRAK-1.
-
体外实验Western Blot Analysis Cell Line:RAW 264.7 cells and THP-1 cells Concentration:10 μM Incubation Time:15 minutes Result:Decreased LPS (100 ng/mL)-induced phosphorylation of IκBα and NF-κB-P65.
-
体内实验Animal Model:C57BL/6 (20-22 g, male) mice Dosage:5 mg/kg and 10 mg/kg Administration:Intraperitoneally injected; 5 days Result:Protected mice from LPS (20 mg/kg)-induced sepsis. Survival at day 5 was 13.3% in control group where septic mice were treated by vehicle, while the values were 37.5% and 56.3% for 5 mg/kg and 10 mg/kg.
-
同义词——
-
通路Immunology/Inflammation
-
靶点IRAK
-
受体IRAK-1
-
研究领域——
-
适应症——
化学信息
-
CAS Number2227368-54-7
-
分子量452.46
-
分子式C25H20N6O3
-
纯度>98% (HPLC)
-
溶解度DMSO:Soluble
-
SMILESO=C(C1=NC(C2=NNC=C2)=CC=C1)NC3=CC=C(NC(C4=CC=CC(NC(C=C)=O)=C4)=O)C=C3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.John M Hatcher, et al.ACS Med Chem Lett.2020 Oct 9;11(11):2238-2243.
产品手册
关联产品
-
IRAK-4 protein kinas...
IRAK-4 蛋白激酶抑制剂 2 是一种有效的白细胞介素 1 受体相关激酶 4 (IRAK-4) 抑制剂 (IC50 = 4 μM)。
-
IRAK inhibitor 1
IRAK抑制剂1是一种有效的IRAK-4抑制剂,IC50为216 nM。
-
IRAK4-IN-20
IRAK4-IN-20 is a potent and orally active IRAK4 inhibitor (IC50:3.55 nM). IRAK4-IN-20, which has anti-inflammatory, antitumor and anticancer effects, is often used to treat acute respiratory distress syndrome (ARDS).
021-51111890
购物车()
sales@molnova.cn

